论文部分内容阅读
我院于1995年8～11月,应用四川美大康药业有限公司生产的利巴韦林治疗幼儿轮状病毒肠炎90例,疗效满意,现报告如下。 资料和方法 病例选择:临床诊断为轮状病毒肠炎的急性腹泻患儿,病程在7天之内,大便呈稀水或水样便者(脓血便者不作观察对象),随机分为利巴韦林治疗组和对照组。治疗组90例.男57例.女33例,年龄:<6月24例.<1岁31例.<2岁25例,<3岁10例。对照组30例,男18例.女12例.年龄:<6月12例,<1岁11例、<2岁4例、<3岁3例。两组患儿治疗前均
Our hospital in August 1995 to November, the application of Sichuan Daxiang Pharmaceutical Co., Ltd. production of ribavirin treatment of infant rotavirus enteritis 90 cases, with satisfactory results, are as follows. Materials and Methods Case Selection: Children with acute diarrhea diagnosed as rotavirus enteritis, the course of the disease was within 7 days, the stool was watery or watery stool (pus and blood were not observed) were randomly divided into three groups: Lin treatment group and control group. Treatment group of 90 patients, 57 males and 33 females, age: <24 cases in June <1 year old in 31. <2 years old in 25 cases, <3 years old in 10 cases. The control group of 30 cases, 18 males and 12 females.Age: <12 months in June, <1 year old in 11 cases, <2 years in 4 cases, <3 years old in 3 cases. Two groups of children before treatment are